AstraZeneca PLC (LON:0A4J)
London
· Delayed Price · Currency is GBP · Price in USD 74.90
-2.49 (-3.22%)
At close: Mar 12, 2025
AstraZeneca Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 7,035 | 5,955 | 3,288 | 112 | 3,196 | Upgrade
|
| Depreciation & Amortization | 4,981 | 4,851 | 5,178 | 4,039 | 2,835 | Upgrade
|
| Other Amortization | 200 | 280 | 292 | 311 | 61 | Upgrade
|
| Loss (Gain) From Sale of Assets | -60 | -292 | -216 | -509 | -1,055 | Upgrade
|
| Asset Writedown & Restructuring Costs | 1,623 | 456 | 226 | 2,428 | 253 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | -776 | - | Upgrade
|
| Loss (Gain) on Equity Investments | 28 | 12 | 5 | 64 | 27 | Upgrade
|
| Stock-Based Compensation | 42 | -71 | 27 | 45 | -72 | Upgrade
|
| Other Operating Activities | -1,095 | -1,146 | -2,749 | -1,772 | -807 | Upgrade
|
| Change in Accounts Receivable | -1,624 | -1,425 | -1,349 | -961 | -739 | Upgrade
|
| Change in Inventory | -131 | -669 | 3,941 | 1,577 | -621 | Upgrade
|
| Change in Accounts Payable | 862 | 2,394 | 1,165 | 1,405 | 1,721 | Upgrade
|
| Operating Cash Flow | 11,861 | 10,345 | 9,808 | 5,963 | 4,799 | Upgrade
|
| Operating Cash Flow Growth | 14.65% | 5.47% | 64.48% | 24.25% | 61.64% | Upgrade
|
| Capital Expenditures | -1,924 | -1,361 | -1,091 | -1,091 | -961 | Upgrade
|
| Sale of Property, Plant & Equipment | 55 | 132 | 282 | 13 | 106 | Upgrade
|
| Cash Acquisitions | -3,782 | -1,099 | -1,035 | -10,117 | -822 | Upgrade
|
| Sale (Purchase) of Intangibles | -2,539 | -2,126 | -1,033 | -522 | -694 | Upgrade
|
| Investment in Securities | -133 | -87 | -143 | 605 | 1,999 | Upgrade
|
| Other Investing Activities | 343 | 477 | 60 | 54 | 87 | Upgrade
|
| Investing Cash Flow | -7,980 | -4,064 | -2,960 | -11,058 | -285 | Upgrade
|
| Short-Term Debt Issued | - | 161 | 74 | - | 288 | Upgrade
|
| Long-Term Debt Issued | 6,492 | 3,816 | - | 12,929 | 2,968 | Upgrade
|
| Total Debt Issued | 6,492 | 3,977 | 74 | 12,929 | 3,256 | Upgrade
|
| Short-Term Debt Repaid | -31 | - | - | -276 | - | Upgrade
|
| Long-Term Debt Repaid | -4,968 | -5,210 | -1,515 | -4,999 | -1,816 | Upgrade
|
| Total Debt Repaid | -4,999 | -5,210 | -1,515 | -5,275 | -1,816 | Upgrade
|
| Net Debt Issued (Repaid) | 1,493 | -1,233 | -1,441 | 7,654 | 1,440 | Upgrade
|
| Issuance of Common Stock | 38 | 33 | 29 | 29 | 30 | Upgrade
|
| Repurchase of Common Stock | -81 | - | - | - | - | Upgrade
|
| Common Dividends Paid | -4,629 | -4,481 | -4,364 | -3,856 | -3,572 | Upgrade
|
| Other Financing Activities | -817 | -886 | -1,047 | -178 | -101 | Upgrade
|
| Financing Cash Flow | -3,996 | -6,567 | -6,823 | 3,649 | -2,203 | Upgrade
|
| Foreign Exchange Rate Adjustments | -93 | -60 | -80 | -62 | 12 | Upgrade
|
| Net Cash Flow | -208 | -346 | -55 | -1,508 | 2,323 | Upgrade
|
| Free Cash Flow | 9,937 | 8,984 | 8,717 | 4,872 | 3,838 | Upgrade
|
| Free Cash Flow Growth | 10.61% | 3.06% | 78.92% | 26.94% | 92.86% | Upgrade
|
| Free Cash Flow Margin | 18.38% | 19.61% | 19.66% | 13.02% | 14.42% | Upgrade
|
| Free Cash Flow Per Share | 6.36 | 5.75 | 5.59 | 3.41 | 2.92 | Upgrade
|
| Cash Interest Paid | 1,313 | 1,081 | 849 | 721 | 733 | Upgrade
|
| Cash Income Tax Paid | 2,750 | 2,366 | 1,623 | 1,743 | 1,562 | Upgrade
|
| Levered Free Cash Flow | 8,461 | 9,008 | 12,485 | -1,845 | 3,441 | Upgrade
|
| Unlevered Free Cash Flow | 9,222 | 9,570 | 12,843 | -1,608 | 3,902 | Upgrade
|
| Change in Net Working Capital | 121 | -1,517 | -3,586 | 6,523 | 347 | Upgrade
|
Updated Feb 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.